 Finally, the court held that N/I harmed the market for the sequels of D/N-3D, where only FormGen has the right to produce a sequel.In conclusion, the court found that "[N/I] neither falls into any of the categories enumerated in section 107 nor meets the four criteria set forth in section 107.